Royston Aaron 4/A
4/A · Menlo Therapeutics Inc. · Filed Aug 8, 2019
Insider Transaction Report
Form 4/AAmended
Royston Aaron
Director
Transactions
- Award
Stock Option
2019-06-25+22,500→ 22,500 totalExercise: $6.02Exp: 2029-06-25→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on the one year anniversary of the transaction date.